Characteristics, clinical features, prevalence of selected risk factors for intracranial hemorrhage, coagulation parameters, and platelet count among patients, controls, and general population
. | Patients with hemorrhage . | Controls . | P . | General population . | ||
---|---|---|---|---|---|---|
PIH N = 141 . | SAH N = 60 . | Total N = 201 . | N = 201 . | N = 490 . | ||
Age (y), mean ± SD | 68.7 ± 13.1 | 60.9 ± 12.3 | 66.4 ± 13.5 | 67.8 ± 12.8 | .282 | 49.5 ± 19.5 |
Male sex (%) | 63.8 | 38.3 | 56.2 | 56.2 | 1.000 | 48.6 |
Hypertension (%) | 65.3 | 36.7 | 56.7 | 59.2 | .572 | ND |
Current/former smoker (%) | 27.7 | 30.0 | 28.4 | 26.4 | .655 | ND |
Alcohol consumption (%) | 7.8 | 8.3 | 8.0 | 6.0 | .441 | ND |
APTT(s): mean ± SD | 26.4 ± 2.2 | 26.6 ± 2.6 | 26.5 ± 2.3 | 26.7 ± 2.2 | .452 | ND |
Platelets × 106/L: mean ± SD | 204.0 ± 35.3 | 221.6 ± 51.4 | 209.3 ± 41.5 | 202.7 ± 18.9 | .078 | ND |
30-day survival (%) | 80.1 | 76.7 | 79.1 | — | — | — |
Aneurysm (%) | — | 70.0 | — | — | — | — |
. | Patients with hemorrhage . | Controls . | P . | General population . | ||
---|---|---|---|---|---|---|
PIH N = 141 . | SAH N = 60 . | Total N = 201 . | N = 201 . | N = 490 . | ||
Age (y), mean ± SD | 68.7 ± 13.1 | 60.9 ± 12.3 | 66.4 ± 13.5 | 67.8 ± 12.8 | .282 | 49.5 ± 19.5 |
Male sex (%) | 63.8 | 38.3 | 56.2 | 56.2 | 1.000 | 48.6 |
Hypertension (%) | 65.3 | 36.7 | 56.7 | 59.2 | .572 | ND |
Current/former smoker (%) | 27.7 | 30.0 | 28.4 | 26.4 | .655 | ND |
Alcohol consumption (%) | 7.8 | 8.3 | 8.0 | 6.0 | .441 | ND |
APTT(s): mean ± SD | 26.4 ± 2.2 | 26.6 ± 2.6 | 26.5 ± 2.3 | 26.7 ± 2.2 | .452 | ND |
Platelets × 106/L: mean ± SD | 204.0 ± 35.3 | 221.6 ± 51.4 | 209.3 ± 41.5 | 202.7 ± 18.9 | .078 | ND |
30-day survival (%) | 80.1 | 76.7 | 79.1 | — | — | — |
Aneurysm (%) | — | 70.0 | — | — | — | — |
PIH, primary intracerebral hemorrhage; SAH, subarachnoid hemorrhage; APTT, activated partial thromboplastin time; ND, not determined. Hypertension was defined as blood pressure exceeding 140 mm Hg systolic or 90 mm Hg diastolic on repeated observations over 3 months or if no blood pressure values were available when the subject was under treatment with chronic antihypertensive therapy. Current/former smoker, subject smoked more than 10 cigarettes per day. Alcohol consumption, subject consumed more than 300 g alcohol per week.